Literature DB >> 17206757

Pathogenesis of hepatitis B virus infection.

Thomas F Baumert1, Robert Thimme, Fritz von Weizsäcker.   

Abstract

Infection with hepatitis B virus (HBV) leads to a wide spectrum of clinical presentations ranging from an asymptomatic carrier state to self-limited acute or fulminant hepatitis to chronic hepatitis with progression to cirrhosis and hepatocellular carcinoma. Infection with HBV is one of the most common viral diseases affecting man. Both viral factors as well as the host immune response have been implicated in the pathogenesis and clinical outcome of HBV infection. In this review, we will discuss the impact of virus-host interactions for the pathogenesis of HBV infection and liver disease. These interactions include the relevance of naturally occurring viral variants for clinical disease, the role of virus-induced apoptosis for HBV-induced liver cell injury and the impact of antiviral immune responses for outcome of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206757      PMCID: PMC4065880          DOI: 10.3748/wjg.v13.i1.82

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  116 in total

1.  Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklings.

Authors:  W L Chuang; M Omata; T Ehata; O Yokosuka; K Hosoda; F Imazeki; M Ohto
Journal:  Hepatology       Date:  1994-03       Impact factor: 17.425

2.  Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Patrick Marcellin; Ting-Tsung Chang; Seng Gee Lim; Myron J Tong; William Sievert; Mitchell L Shiffman; Lennox Jeffers; Zachary Goodman; Michael S Wulfsohn; Shelly Xiong; John Fry; Carol L Brosgart
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

3.  The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.

Authors:  William E Delaney; Huiling Yang; Christopher E Westland; Kalyan Das; Eddy Arnold; Craig S Gibbs; Michael D Miller; Shelly Xiong
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal.

Authors:  Kyun-Hwan Kim; Baik L Seong
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

5.  Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R.

Authors:  Tatyana Kalinina; Alicja Iwanski; Hans Will; Martina Sterneck
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

6.  Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Authors:  Peter Angus; Rhys Vaughan; Shelly Xiong; Huiling Yang; William Delaney; Craig Gibbs; Carol Brosgart; Danielle Colledge; Rosalind Edwards; Anna Ayres; Angeline Bartholomeusz; Stephen Locarnini
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

7.  De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.

Authors:  Mengji Lu; Thomas Lorentz
Journal:  J Infect Dis       Date:  2003-03-26       Impact factor: 5.226

8.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.

Authors:  K Yamamoto; M Horikita; F Tsuda; K Itoh; Y Akahane; S Yotsumoto; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis.

Authors:  C Lamberts; M Nassal; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  39 in total

1.  Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.

Authors:  Wei Cao; Zhi-Feng Qiu; Tai-Sheng Li
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

Review 2.  Recent advances in hepatitis B virus research: a German point of view.

Authors:  Dieter Glebe
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.

Authors:  Jin-Lin Cheng; Hong Zhao; Shi-Gui Yang; Er-Mei Chen; Wen-Qian Chen; Lan-Juan Li
Journal:  Hepatol Int       Date:  2018-06-07       Impact factor: 6.047

4.  Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Authors:  Takashi Hoshino; Hitoshi Takagi; Yuhei Suzuki; Atsushi Naganuma; Ken Sato; Satoru Kakizaki; Tsutomu Nishizawa; Hiroaki Okamoto; Masanobu Yamada
Journal:  Clin J Gastroenterol       Date:  2016-05-10

Review 5.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

Review 6.  Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.

Authors:  Zhuo-Lun Song; Yu-Jun Cui; Wei-Ping Zheng; Da-Hong Teng; Hong Zheng
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 7.  Clinical impact of hepatitis B and C virus envelope glycoproteins.

Authors:  Hélène Jeulin; Aurélie Velay; John Murray; Evelyne Schvoerer
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 8.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

9.  Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.

Authors:  Jing You; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Lin Zhuang; Hong-Ying Chen; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates.

Authors:  Maisa M Ali; Fuad Hasan; Suhail Ahmad; Widad Al-Nakib
Journal:  Virol J       Date:  2010-05-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.